EPS Q/Q společnosti Navidea Biopharmaceuticals Inc
Jaká je hodnota metriky EPS Q/Q společnosti Navidea Biopharmaceuticals Inc?
Hodnota metriky EPS Q/Q společnosti Navidea Biopharmaceuticals Inc je -38.46%
Jaká je definice metriky EPS Q/Q?
Čtvrtletní růst EPS (Quarterly EPS growth rate) ze čtvrtletí na čtvrtletí, je nárůst EPS společnosti za poslední čtyři čtvrtletí v porovnání s výsledky z minulých čtyř čtvrtletí.
The earnings per share growth rate is an important factor for judging a company's value. EPS growth rate gives a good picture of the rate at which the company has grown its profitability in respect to the total number of shares. Comparing EPS history with stock price history helps determine the most likely future direction of the stock price.
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
EPS Q/Q společností v sektoru Health Care sektor na NYSEMKT ve srovnání se společností Navidea Biopharmaceuticals Inc
Čemu se věnuje společnost Navidea Biopharmaceuticals Inc?
navidea biopharmaceuticals, inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. it operates through two segments, diagnostic substances and therapeutic development programs. the company develops manocept platform to target the cd206 mannose receptor expressed on activated macrophages. its cd206-targeted drug platform is applicable to a range of diagnostic modalities, including single photon emission computed tomography, positron emission tomography (pet), imaging and topical gamma-scanning, and intra-operative and/or optical-fluorescence detection, as well as delivery of therapeutic compounds that target macrophages, and immune-and inflammation-involved diseases. further, the company offers nav4694, a fluorine-18 labeled pet imaging agent for use as an aid in the imaging and evaluation of patients with signs or symptoms of alzheimer's disease and mild cognitive impairment. in addition, it is de
Firmy s metrikou eps q/q podobnou společnosti Navidea Biopharmaceuticals Inc
- Hodnota metriky EPS Q/Q společnosti Akzo Nobel NV je -38.71%
- Hodnota metriky EPS Q/Q společnosti Aeglea BioTherapeutics Inc je -38.71%
- Hodnota metriky EPS Q/Q společnosti InflaRx N.V je -38.71%
- Hodnota metriky EPS Q/Q společnosti GE Aerospace je -38.60%
- Hodnota metriky EPS Q/Q společnosti Semler Scientific je -38.55%
- Hodnota metriky EPS Q/Q společnosti First Foundation Inc je -38.55%
- Hodnota metriky EPS Q/Q společnosti Navidea Biopharmaceuticals Inc je -38.46%
- Hodnota metriky EPS Q/Q společnosti J&J Snack Foods je -38.41%
- Hodnota metriky EPS Q/Q společnosti Stemline Therapeutics je -38.36%
- Hodnota metriky EPS Q/Q společnosti Black Diamond Therapeutics Inc je -38.14%
- Hodnota metriky EPS Q/Q společnosti AngloGold Ashanti Plc je -38.10%
- Hodnota metriky EPS Q/Q společnosti Franklin Resources je -38.10%
- Hodnota metriky EPS Q/Q společnosti Allena Pharmaceuticals Inc je -38.10%